Aptivus FDA Approval History
FDA Approved: Yes (First approved June 22, 2005)
Brand name: Aptivus
Generic name: tipranavir
Dosage form: Capsules
Company: Boehringer Ingelheim
Treatment for: HIV Infection
Aptivus (tipranavir) is a non-peptidic protease inhibitor which is co-administered with ritonavir for the treatment of HIV Infection.
Development Timeline for Aptivus
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.